Moveltipril

This classification denotes an ace inhibitor with the molecular formula C19H30N2O5S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier LQI0441316, chemically known as (-)-1-((2s)-3-mercapto-2-methylpropionyl)-l-proline, ester with n-(cyclohexyl-carbonyl)thio-d-alanine. but generally known as moveltipril, which bears US NIH Compound Identifier 5745793. European Medicines Agency schedules Moveltipril in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09078MIG. The term MOVELTIPRIL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 2, No. 3, 1988, List 28). MOVELTIPRIL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule moveltipril under HS 29339990 and SITC 51577. As of Q4 2014, MOVELTIPRIL remains the US FDA Preferred Term for this commodity. Moveltipril bears US NLM identifiers UMLS ID C2981287 and NCI Concept Code C87574. SMILES: S(CC(C(=O)N1C(CCC1)C(=O)O)C)C(=O)C(NC(=O)C1CCCCC1)C.